2768-56-1 Usage
Description
N-CARBOBENZOXY-DL-SERINE, also known as Z-DL-Serine, is a derivative of the primary amino acid serine. It is a white powder with unique chemical properties that make it suitable for various applications across different industries.
Uses
Used in Pharmaceutical Industry:
N-CARBOBENZOXY-DL-SERINE is used as an intermediate in the synthesis of various pharmaceutical compounds for [application reason]. Its unique chemical structure allows for the development of new drugs with potential therapeutic benefits.
Used in Chemical Synthesis:
In the chemical industry, N-CARBOBENZOXY-DL-SERINE is used as a building block for the creation of complex organic molecules for [application reason]. Its reactivity and versatility make it a valuable component in the synthesis of specialty chemicals.
Used in Research and Development:
N-CARBOBENZOXY-DL-SERINE is utilized as a research compound in the field of biochemistry and molecular biology for [application reason]. It aids in the study of protein synthesis, enzyme mechanisms, and other biological processes, contributing to the advancement of scientific knowledge.
Used in Cosmetics Industry:
In the cosmetics industry, N-CARBOBENZOXY-DL-SERINE is used as an active ingredient in skincare products for [application reason]. Its properties may contribute to improved skin health and appearance, making it a valuable addition to cosmetic formulations.
Please note that the specific application reasons for each industry are not provided in the materials. You may need to research or consult with experts in the respective fields to determine the exact reasons for their use.
Check Digit Verification of cas no
The CAS Registry Mumber 2768-56-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,7,6 and 8 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 2768-56:
(6*2)+(5*7)+(4*6)+(3*8)+(2*5)+(1*6)=111
111 % 10 = 1
So 2768-56-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H13NO5/c13-6-9(10(14)15)12-11(16)17-7-8-4-2-1-3-5-8/h1-5,9,13H,6-7H2,(H,12,16)(H,14,15)/p-1/t9-/m1/s1
2768-56-1Relevant articles and documents
Primary amino acid derivatives: Compounds with anticonvulsant and neuropathic pain protection activities
King, Amber M.,Salomé, Christophe,Dinsmore, Jason,Salomé-Grosjean, Elise,De Ryck, Marc,Kaminski, Rafal,Valade, Anne,Kohn, Harold
supporting information; experimental part, p. 4815 - 4830 (2011/10/01)
Pharmacological management remains the primary method to treat epilepsy and neuropathic pain. We have advanced a novel class of anticonvulsants termed functionalized amino acids (FAAs). In this study, we examine FAA derivatives from which the terminal acetyl moiety was removed and termed these compounds primary amino acid derivatives (PAADs). Twenty-seven PAADs were prepared; the central C(2) R-substituent was varied, including C(2) stereochemistry, and the compounds were tested in rodent models of seizures and neuropathic pain. C(2)-Hydrocarbon N-benzylamide PAADs were potent anticonvulsants and excellent anticonvulsant activity (mice, ip; rat, po) was observed for C(2) R-substituted PAADs in which the R group was ethyl, isopropyl, or tert-butyl, and the C(2) stereochemistry conformed to the d-amino acid configuration ((R)-stereoisomer). These values surpassed the activities of several clinical antiepileptic drugs. The C(2) (R)-ethyl and C(2) (R)-isopropyl PAADs also displayed excellent activities in the mouse (ip) formalin neuropathic pain model. Significantly, unlike the FAA structure-activity relationship, PAAD anticonvulsant activity increased upon substitution of a methylene unit for a heteroatom in the R-substituent that was one atom removed from the C(2) site, suggesting that these PAADs function by a different pathway than FAAs.
Composition containing a penem or carbapenem antibiotic and the use of the same
-
, (2008/06/13)
Administration of an N-acylated amino acid in association with a penem or carbapenem antibiotic relieves or eliminates the renal problems associated with administration of the antibiotic alone. The amino acid derivative and antibiotic may be formulated together as a composition or administered separately, either simultaneously or sequentially.